NALOREX

50mg Milligram Tablets

Bristol-Myers Squibb Pharmaceuticals LtdPA0002/070/001

SPC: DATE OF REVISION OF THE TEXT

16 May 2015 - 20 Oct 2016	20 Oct 2016 - Present
January 2015	October 2016

« Back

Follow medicine

Print

Latest Changes to Medicine Info & SPC

20 Oct 2016
SPC: DATE OF REVISION OF THE TEXT
20 Oct 2016
SPC: List of excipients
20 Oct 2016
SPC: Preclinical safety data
20 Oct 2016
SPC: Undesirable effects
20 Oct 2016
SPC: Fertility, pregnancy and lactation
20 Oct 2016
SPC: Interaction with other medicinal products and other forms of interaction
20 Oct 2016
SPC: Special warnings and precautions for use
20 Oct 2016
SPC: Contraindications
20 Oct 2016
SPC: Posology and method of administration
20 Oct 2016
SPC: QUALITATIVE AND QUANTITATIVE COMPOSITION
23 Jul 2016
Promotion Status
23 Jul 2016
Supply Status
21 Jul 2016
Promotion Status
21 Jul 2016
Supply Status
25 Aug 2015
ATC Code(s)

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.

NALOREX

SPC: DATE OF REVISION OF THE TEXT

Latest Changes to Medicine Info & SPC

Important information regarding cookies and the HPRA